logo
welcome
Reuters

Reuters

Novo Nordisk lifts curbs on Wegovy prescriptions in the U.S., says CEO

Reuters
Summary
Nutrition label

80% Informative

Novo Nordisk is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States .

CEO Lars Fruergaard Jorgensen said the slower pace of weekly prescriptions in the last couple of months was due to lower starter doses being supplied into the market.

VR Score

90

Informative language

94

Neutral language

86

Article tone

semi-formal

Language

English

Language complexity

53

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links